Dr Michelle Asha Handy, PHARMD, MBA | |
1830 Oak Dr, Alva, FL 33920-3707 | |
(239) 707-6994 | |
Not Available |
Full Name | Dr Michelle Asha Handy |
---|---|
Gender | Female |
Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
Location | 1830 Oak Dr, Alva, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174923635 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | PS48161 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Michelle Asha Handy, PHARMD, MBA 1830 Oak Dr, Alva, FL 33920-3707 Ph: (239) 707-6994 | Dr Michelle Asha Handy, PHARMD, MBA 1830 Oak Dr, Alva, FL 33920-3707 Ph: (239) 707-6994 |
News Archive
Sorbent Therapeutics, Inc., a biopharmaceutical company developing therapies for cardiovascular and renal diseases, today announced that patient dosing has commenced in its Phase 2b clinical trial of CLP-1001.
In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.
Eliminating financial barriers to a fitness center as well as providing physician support, a pleasant environment and trained fitness staff did not result in widespread membership activation or consistent attendance among low income, multi-ethnic women with chronic disease risk factors or diagnoses according to a new study from Boston University School of Medicine.
Despite herculean efforts, cancer remains a formidable disease, with each malignant subtype responding differently to therapeutics.
› Verified 4 days ago